Preparation method of L-erythro biopterin compound
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANGHAI FOREFRONT PHARMA CO LTD
- Publication Date
- 2021-02-23
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of medicine preparation, in particular to a preparation method of L-erythrotype biopterin compounds. Background technique
[0002] Formula (I) indicates that L-erythro-biopterin compounds are important intermediates of most drugs at present, especially sapropterin drugs. For example: (R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-5,6,7,8-tetrahydro-4( 3H)-pteridinone (BH4), which is an essential coenzyme in hydroxylation reaction and oxygenase in organisms, is the most important coenzyme of nitric oxide synthase (NOS), and its hydrochloride (i.e. dihydrochloride sapyl Pterin, whose structural formula is formula (I-3)) has been approved by many countries for the treatment of phenylketonuria.
[0003]
[0004] And the main method of synthesizing sapropterin dihydrochloride at present is to obtain by hydrogenation reduction of the compound shown in formula (I-1).
[0005]
[0006] Therefore, how to safely...